Evidence map›Paper›PMID 42605469›Full record

ArticleIranian journal of pathology2026

Uncovering the Pleomorphic Hyalinizing Angiectatic Tumor: A Case Series and Literature Review.

Jaydeep Nilkanthrao Pol, Manasi Gosavi, Rakhi Vikas Jagdale, Mahendra Atmaram Patil, Anand Bhosale

Abstract readCase Reports
In one paragraph

Article in Iranian journal of pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jaydeep Nilkanthrao PolDepartment of Surgical Pathology, Mahatma Gandhi Cancer Hospital, Miraj, Maharashtra, India.ORCID https://orcid.org/0000-0001-9962-753X
Manasi GosaviDepartment of Pathology, KAHER's Jawaharlal Nehru Medical College, Belagavi, Karnataka, India.ORCID https://orcid.org/0000-0003-4283-134X
Rakhi Vikas JagdaleDepartment of Pathology, Shri Siddhivinayak Ganapati Cancer Hospital, Miraj, Maharashtra, India.
Mahendra Atmaram PatilKrishna Vishwa Vidyapeeth, Malkapur, Karad district, Satara, Maharashtra, India.
Anand BhosaleDepartment of Pathology, D. Y. Patil University School of Medicine and Pushpalata D. Y. Patil Hospital, Ambi, Pune, Maharashtra, India.ORCID https://orcid.org/0000-0002-8851-2507

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background & Objective: Pleomorphic hyalinizing angiectatic tumor (PHAT) is a rare fibrohistiocytic neoplasm, classified by the World Health Organization (WHO) as a "neoplasm of uncertain behavior of connective or soft tissue" within the soft tissue and bone tumor group. A literature review via Scopus and PubMed revealed approximately 133 reported cases worldwide, affecting individuals aged 10 to 86 years, with a slight female predominance and wide anatomical distribution. Case Presentation: We report a series of 4 PHAT cases, the first from India and the fourth largest globally. The cases include a 37-year-old male with a large upper abdominal wall mass, a 46-year-old male with a forearm swelling, a 36-year-old female with a lower leg mass, and a 40-year-old male with a lower abdominal mass. Histopathology showed characteristic features, including ectatic vessels, hyalinization, and pleomorphic spindle cells. Conclusion: Given its rarity and histologic overlap with other tumors, increased awareness and accurate histopathological diagnosis of PHAT are essential.

Indexed as

angiectatic tumorfibrohistiocytic tumorintermediate malignancyPleomorphic hyalinizing angiectatic tumorpleomorphismrecurrencesoft tissue neoplasm

Identifiers

PMID42605469
PMCPMC13477777

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.